Niagen Bioscience (NAGE) Debt Ratio (2016 - 2018)

Niagen Bioscience (NAGE) reported Debt Ratio of 0.0 for Q4 2018, down 34.36% year-over-year from 0.0 in Q4 2017, and down 34.36% quarter-over-quarter from 0.0 in Q4 2017.

Niagen Bioscience (NAGE) Debt Ratio (2016 - 2018) Analysis & Trends

Niagen Bioscience (NAGE) has 3 years of Debt Ratio data on file, last reported at 0.0 in Q4 2018.

  • Debt Ratio for Q4 2018 came in at 0.0, down 34.36% year-over-year; the trailing twelve-month figure through Dec 2018 was 0.0 (down 34.36% YoY), and the FY2018 annual result was 0.0, down 34.36% from the prior year.
  • Debt Ratio slipped to 0.0 in Q4 2018 per NAGE's latest filing, from 0.0 in the prior quarter.
  • Over five years, Debt Ratio peaked at 0.26 in Q1 2016 and troughed at 0.0 in Q4 2018.
  • A 3-year average of 0.07 and a median of 0.01 in 2016 frame the typical range for Debt Ratio.
  • The sharpest annual moves came in 2016 and 2018: Debt Ratio plunged 93.3% in 2016, then slumped 34.36% in 2018.
  • A 3-year view of Debt Ratio shows it stood at 0.02 in 2016, then plunged by 71.62% to 0.0 in 2017, then tumbled by 34.36% to 0.0 in 2018.
  • Business Quant data shows NAGE's Debt Ratio at 0.0 in Q4 2018, 0.0 in Q4 2017, and 0.02 in Q4 2016.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Alterity Therapeutics 719,706.53 Bn 719,706.50 Bn - -
2 Belite Bio 55,800.00 Bn 55,800.00 Bn - -
3 Quantum Biopharma 18,182.30 Bn 18,182.29 Bn - -
4 Legend Biotech 3,154.00 Bn 3,153.71 Bn 242.10 Mn 0.18
5 Akari Therapeutics 1,844.30 Bn 1,844.29 Bn - -
6 Evaxion A 1,567.96 Bn 1,567.94 Bn - -
7 Psyence Biomedical 251.43 Bn 251.42 Bn - -
8 Vertex Pharmaceuticals 112.56 Bn 105.31 Bn 2.59 Bn -
9 Abivax 94.37 Bn 94.37 Bn - -
10 Niagen Bioscience 269.32 Mn 202.77 Mn 19.98 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2018 0.00
Dec 30, 2017 0.00
Dec 31, 2016 0.02
Jan 2, 2016 0.26